Nine-Market Comparison of Medical Device Registration Metrics
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Placing the nine markets that GRZAN has already delivered side by side, the differences concentrate in five dimensions: the competent authority, the structure of the pathway, the validity of the certificate, whether a local representative is mandatory, and the language of the label. Among these, the item most easily overlooked is that validity rules are not uniform — some markets operate on permanent validity maintained through annual fees, others require renewal every five years, and misjudging this leads directly to a certificate lapsing. The mistake is common because validity is the dimension that looks similar from a distance: every market ends up holding some kind of certificate, so teams assume the maintenance logic is also similar. It is not. A renewal date that exists in one market has no equivalent in another, and an annual fee that keeps a licence alive in one jurisdiction does nothing for a neighbour with a fixed five-year term. Companies running multi-market portfolios should treat validity mechanics as a per-market fact to be verified, never as an assumption carried across borders from the last project.
2. Legal basis
The table below summarises the current framework of each market across the five dimensions. Each row reflects the instrument or authority named in that market; the validity column deserves particular attention because it is the field where cross-market assumptions most often fail.
| Market | Competent authority | Pathway / certificate | Validity | Local representative | Label language |
| Malaysia | MDA (Act 737) | registration after review by a CAB (MDR 2012, P.U.(A) 500/2012) | 5 years | foreign manufacturers must have an AR | English / Malay |
| Indonesia | Kemenkes (Ditjen Farmalkes) | AKL / AKD (NIE), IDAK + CDAKB | 5 years | must be a local licence holder + importer | Indonesian mandatory |
| Vietnam | MOH / IMDA | số lưu hành (MAC), Circular 05/2022 | no fixed validity | local representative required | Vietnamese |
| Thailand | Thai FDA / MDCD | Class 1 Listed; Class 2/3 Notified; Class 4 Licensed | licence 5 years | licence holder = importer = AR, a single Thai entity | Thai |
| Singapore | HSA | Class A exempt from registration; B/C/D registration (Immediate / Expedited / Abridged / Full) | no fixed validity, maintained by annual fee | foreign manufacturers must have a local representative | English |
| Philippines | FDA / CDRRHR | Class A CMDN; B/C/D CMDR (AO 2018-0002) | 5 years | local licence holder required | English |
| India | CDSCO (CLA/SLA) | import licence (MDR 2017, G.S.R. 78(E)) | permanent validity + 5-year retention fee | an AR is required | English |
| Bangladesh | DGDA | two steps: formulation approval + final registration (Class A by listing / DoC) | Class A without term; B/C/D 5 years | an LAR is required | English / Bengali |
| Pakistan | DRAP / MDMC (MDB) | Class A Enlistment; B/C/D Registration | 5 years | the licensed importer is the AR (Rule 14(1)(b)) | English, with key safety information and basic instructions for household devices in Urdu |
3. Expert insights
Insight one: Pakistan, Thailand and Indonesia share the strongly bound structure in which the local entity is the licence holder. What the three have in common is that the name on the certificate and the entity clearing goods through customs are one and the same. This determines that the cost of changing distribution channels is extremely high, and an exit mechanism must be designed at the contract stage. When the registration and the import function sit in the same company, a commercial dispute with that company threatens not just sales but the product’s very authorisation to remain in the market. The negotiation leverage that a manufacturer believes it holds often evaporates once the certificate has been issued in the partner’s name, which is why the exit terms are worth their weight in legal fees long before any dispute exists.
Insight two: Singapore and India belong to the permanent-validity camp, while most of the others renew every five years. Singapore maintains validity through annual fees (with cancellation after 60 days overdue), and India through the five-year retention fee (with a 2 per cent monthly surcharge for late payment). Applying Singapore’s experience to Pakistan is the most common cause of certificates lapsing. A team trained on a fee-maintained licence assumes that paying money on time is the whole obligation, and simply misses the renewal filing that a fixed-term system requires. The two maintenance models demand different calendars, different budgets and different responsible persons, so the portfolio tooling must reflect the difference rather than average over it.
Insight three: Vietnam is the exception among the validity rules. The MAC carries no fixed validity, which runs against the five-year intuition. Chinese-language materials frequently state that the Vietnamese registration certificate is valid for five years, and that is an incorrect statement. The error propagates because five years is indeed the modal answer across the region, so writers copy the regional default onto Vietnam without checking. In a comparison exercise the lesson generalises: every cell of a table like this one should carry a citation, because the cost of one wrong cell is a lapsed authorisation in exactly the market nobody was watching.
4. Practical recommendations
On projects that run several markets in parallel, GRZAN works with one comparison table plus nine certificate ledgers: the comparison table supports decisions at the strategic level, such as which market to enter first and how to sequence resources, while the ledgers support management at the execution level, recording for every certificate when it expires and who is responsible for renewing it. Only with the two tools together does multi-country registration stay under control. The comparison table without the ledgers produces confident strategy and missed deadlines; the ledgers without the comparison table produce punctual administration and directionless strategy. Each tool catches the failure mode of the other, and the pair is cheap to maintain relative to the cost of a single lapsed certificate in any one of the nine markets.
5. Verification checklist
- □ The competent authority and the pathway name of the target market have been confirmed (enlistment / registration / listing / notification / licence)
- □ The certificate validity rule of that market has been confirmed (whether it is permanent validity maintained by fees)
- □ Whether a local representative is mandatory, and the legal term used for it, have been confirmed
- □ The label language requirement has been confirmed (whether the local language is mandatory)
- □ Renewal ledgers have been established separately according to each market’s rules
Regulatory information verified as of October 28, 2026.
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including Pakistan. Our team prepares dossiers to DRAP expectations, manages eCTD-format submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us